Acquired secondary polycythemia Advocacy Hub | UniteRare

At a Glance

Live from database

💊

Regulatory Watchboard

No FDA or trial events recorded yet for Acquired secondary polycythemia.

Financial Assistance

2 programs

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Patient Assistance Programs2

Inrebic

Celgene Corporation

OpenContact for details

Vonjo

Sobi, Inc.

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

2 FDA-approved

Vonjo

(PACRITINIB)Orphan drugaccelerated

Sobi, Inc.

FDA label ↗

Inrebic

(FEDRATINIB HYDROCHLORIDE)Orphan drugstandard

Celgene Corporation

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Acquired secondary polycythemia.
Search all trials →

Search clinical trials for Acquired secondary polycythemia →

Recent News & Research

3 articles

BREAKINGFDA

FDA Approves VONJO

VONJO (PACRITINIB CITRATE) received FDA approval.

Read ↗

BREAKINGFDA

FDA Approves INREBIC

INREBIC (FEDRATINIB HYDROCHLORIDE) received FDA approval.

Read ↗

BREAKINGFDA

FDA Approves OJJAARA

OJJAARA (MOMELOTINIB DIHYDROCHLORIDE) received FDA approval.

Read ↗

Browse all Acquired secondary polycythemia news →

Specialist Network

No specialists currently listed for Acquired secondary polycythemia.

View all Acquired secondary polycythemia specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰